Survival rate and prognostic factors of esophageal cancer in East Azerbaijan province, North-west of Iran

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 7, 2012, Pages 3451-3454

  Mirinezhad, Seyed Kazem ^a   Somi, Mohammad Hossein ^a   Jangjoo, Amir Ghasemi ^b   Seyednezhad, Farshad ^b   Dastgiri, Saeed ^c   Mohammadzadeh, Mohammad ^b   Naseri, Ali Reza ^b   Nasiri, Behnam ^b  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cox proportional hazard model; Esophageal cancer; Iran; Kaplan meier; Prognosis; Survival

Indexed keywords

EID: 84873601646     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.7.3451     Document Type: Article

References (19)

1. Aghcheli K, Haji-min Marjani A, Nasrollahzadeh D, et al (2011). Prognostic factors for esophageal squamous cell carcinoma-a population-based study in Golestan province, Iran, a High Incidence Area. PLoS ONE, 6, 1-7.
2. Aghajanzadeh M, Rahimi A, Partovian M, Golalizadeh D, Moghaddamnia M (2009). The survival of patients with esophageal cancer after chemoradiation versus surgery and chemoradiation. J Guilan Univers Med Sci, 71, 13-8
3. Alidina A, Gaffar A, Hussain F, et al (2004). Survival data and prognostic factors seen in Pakistani patients with esophageal cancer. Ann Oncol, 15, 118-22.
4. Bashash M, Hislop TG, Shah AM, et al (2011).The prognostic effect of ethnicity for gastric and esophageal cancer: the population-based experience in British Columbia, Canada. BMC Cancer, 11, 164.
5. Bashash M, Shah A, Hislop G, et al (2008). Incidence and survival for gastric and esophageal cancer diagnosed in British Columbia, 1990 to 1999. Can J Gastroenterol, 22, 143-8.
6. Courrech Staal EF, van Coevorden F, Cats A, et al (2009). Outcome of low-volume surgery for esophageal cancer in a high-volume referral centre. Ann Surg Oncol, 16, 3219-26.
7. Gaur P, Sepesi B, Hofstetter WL, et al (2010). Endoscopic esophageal tumor length: a prognostic factor for patients with esophageal cancer. Cancer, 117, 63-9.
8. Ghadimi M, Rasouli M, Mahmoodi M, Mohammad K (2011). Prognostic factors for the survival of patients with esophageal cancer in Northern Iran. J Res Med Sci, 16, 1261-72.
9. Hajian-Tilaki K.O (2001). Factors affecting the survival of patients with esophageal carcinoma under radiotherapy in the north of Iran. Br J Cancer, 85, 1671-4.
10. Hussain SK, Lenner P, Sundquist J, Hemminki K (2008). Influence of education level on cancer survival in Sweden. Annals of Oncology, 19, 156-62.
11. Nomura M, Shitara K, Kodaira T, et al (2012). Prognostic impact of the 6th and 7th American joint committee on cancer tnm staging systems on esophageal cancer patients treated with chemoradiotherapy. Int J Radiation Oncol Biol Phys, 82, 946-52.
12. Rades D, Lang S, Schild SE, Alberti W (2006). Prognostic value of haemoglobin levels during concurrent radiochemotherapy in the treatment of oesophageal cancer. Clin Oncol, 18, 139-44.
13. Samadi F, Babaei M, Yazdanbod A, et al (2007). Survival rate of gastric and esophageal cancers in Ardabil province, North-West of Iran. Arch Iran Med, 10, 32-7.
14. Shitara K, Matsuo K, Hatooka S, et al (2010). Heavy smoking history interacts with chemoradiotherapy for esophageal cancer prognosis: a retrospective study. Cancer Sci, 101, 1001-6.
15. Somi M H, Farhang S, Mirinezhad S K, et al (2008). Cancer in East Azerbaijan, Iran: Results of a Population-based Cancer Registry. Asian Pac J Cancer Prev, 9, 327-30.
16. Sundelof M, Lagergren J, Ye W (2008). Patient demographics and lifestyle factors influencing long-term survival of esophageal cancer and gastric cardiac cancer in a nationwide study in Sweden. Eur J Cancer, 44, 1566-71.
17. Taziki M, Rajaee S, Behnampour N, Tadrisee M, Mansourian AR (2011). Esophageal cancer: 5-year survival rate at south-east of Caspian sea of northern Iran. J Cancer Res Ther, 7, 135-7.
18. Verhoef C, van de Weyer R, Schaapveld M, Bastiaannet E, Plukker JT (2007). Better survival in patients with esophageal cancer after surgical treatment in university hospitals: a plea for performance by surgical oncologists. Ann Surg Oncol, 14, 1678-87.
19. Zafirellis K, Dolan K, Fountoulakis A, et al (2002). Multivariate analysis of clinical, operative and pathologic features of esophageal cancer: who needs adjuvant therapy? Dis Esophagus, 15, 155-9.